Literature DB >> 20734028

The effect of acute exercise on undercarboxylated osteocalcin in obese men.

I Levinger1, R Zebaze, G Jerums, D L Hare, S Selig, E Seeman.   

Abstract

SUMMARY: The purpose of this study was to examine if the reduction in glucose post-exercise is mediated by undercarboxylated osteocalcin (unOC). Obese men were randomly assigned to do aerobic or power exercises. The change in unOC levels was correlated with the change in glucose levels post-exercise. The reduction in glucose post-acute exercise may be partly related to increased unOC.
INTRODUCTION: Osteocalcin (OC) in its undercarboxylated (unOC) form may contribute to the regulation of glucose homeostasis. As exercise reduces serum glucose and improves insulin sensitivity in obese individuals and individuals with type 2 diabetes (T2DM), we hypothesised that this benefit was partly mediated by unOC.
METHODS: Twenty-eight middle-aged (52.4 ± 1.2 years, mean ± SEM), obese (BMI = 32.1 ± 0.9 kg m(-2)) men were randomly assigned to do either 45 min of aerobic (cycling at 75% of VO(2peak)) or power (leg press at 75% of one repetition maximum plus jumping sequence) exercises. Blood samples were taken at baseline and up to 2 h post-exercise.
RESULTS: At baseline, unOC was negatively correlated with glucose levels (r = -0.53, p = 0.003) and glycosylated haemoglobin (HbA1c) (r = -0.37, p = 0.035). Both aerobic and power exercises reduced serum glucose (from 7.4 ± 1.2 to 5.1 ± 0.5 mmol L(-1), p = 0.01 and 8.5 ± 1.2 to 6.0 ± 0.6 mmol L(-1), p = 0.01, respectively). Aerobic exercise significantly increased OC, unOC and high-molecular-weight adiponectin, while power exercise had a limited effect on OC and unOC. Overall, those with higher baseline glucose and HbA1c had greater reductions in glucose levels after exercise (r = -0.46, p = 0.013 and r = -0.43, p = 0.019, respectively). In a sub-group of obese people with T2DM, the percentage change in unOC levels was correlated with the percentage change in glucose levels post-exercise (r = -0.51, p = 0.038).
CONCLUSIONS: This study reports that the reduction in serum glucose post-acute exercise (especially aerobic exercise) may be partly related to increased unOC.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20734028     DOI: 10.1007/s00198-010-1370-7

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  22 in total

1.  The calciotropic hormone response to changes in serum calcium during exercise in female long distance runners.

Authors:  S K Grimston; K E Tanguay; C M Gundberg; D A Hanley
Journal:  J Clin Endocrinol Metab       Date:  1993-04       Impact factor: 5.958

2.  Acute effects of a single session of aerobic exercise with or without weight-lifting on bone turnover in healthy young women.

Authors:  Aliye Tosun; Nesrin Bölükbaşi; Elif Cingi; Mehmet Beyazova; Mustafa Unlü
Journal:  Mod Rheumatol       Date:  2006       Impact factor: 3.023

3.  Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women: the EPIDOS Study.

Authors:  P Vergnaud; P Garnero; P J Meunier; G Bréart; K Kamihagi; P D Delmas
Journal:  J Clin Endocrinol Metab       Date:  1997-03       Impact factor: 5.958

4.  Enhanced adiponectin multimer ratio and skeletal muscle adiponectin receptor expression following exercise training and diet in older insulin-resistant adults.

Authors:  Valerie B O'Leary; Ashley E Jorett; Christine M Marchetti; Frank Gonzalez; Susan A Phillips; Theodore P Ciaraldi; John P Kirwan
Journal:  Am J Physiol Endocrinol Metab       Date:  2007-05-08       Impact factor: 4.310

Review 5.  Skeletal muscle glucose uptake during exercise: a focus on reactive oxygen species and nitric oxide signaling.

Authors:  Troy L Merry; Glenn K McConell
Journal:  IUBMB Life       Date:  2009-05       Impact factor: 3.885

6.  Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice.

Authors:  Mathieu Ferron; Eiichi Hinoi; Gerard Karsenty; Patricia Ducy
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-24       Impact factor: 11.205

Review 7.  A paradigm of integrative physiology, the crosstalk between bone and energy metabolisms.

Authors:  Cyrille B Confavreux; Robert L Levine; Gerard Karsenty
Journal:  Mol Cell Endocrinol       Date:  2009-04-17       Impact factor: 4.102

8.  Endocrine regulation of energy metabolism by the skeleton.

Authors:  Na Kyung Lee; Hideaki Sowa; Eiichi Hinoi; Mathieu Ferron; Jong Deok Ahn; Cyrille Confavreux; Romain Dacquin; Patrick J Mee; Marc D McKee; Dae Young Jung; Zhiyou Zhang; Jason K Kim; Franck Mauvais-Jarvis; Patricia Ducy; Gerard Karsenty
Journal:  Cell       Date:  2007-08-10       Impact factor: 41.582

9.  FoxO1 expression in osteoblasts regulates glucose homeostasis through regulation of osteocalcin in mice.

Authors:  Marie-Therese Rached; Aruna Kode; Barbara C Silva; Dae Young Jung; Susan Gray; Helena Ong; Ji-Hye Paik; Ronald A DePinho; Jason K Kim; Gerard Karsenty; Stavroula Kousteni
Journal:  J Clin Invest       Date:  2009-12-14       Impact factor: 14.808

10.  Adiponectin and AMP kinase activator stimulate proliferation, differentiation, and mineralization of osteoblastic MC3T3-E1 cells.

Authors:  Ippei Kanazawa; Toru Yamaguchi; Shozo Yano; Mika Yamauchi; Masahiro Yamamoto; Toshitsugu Sugimoto
Journal:  BMC Cell Biol       Date:  2007-11-29       Impact factor: 4.241

View more
  24 in total

Review 1.  A four-season molecule: osteocalcin. Updates in its physiological roles.

Authors:  Giovanni Lombardi; Silvia Perego; Livio Luzi; Giuseppe Banfi
Journal:  Endocrine       Date:  2014-08-27       Impact factor: 3.633

Review 2.  The role of osteocalcin in the endocrine cross-talk between bone remodelling and energy metabolism.

Authors:  P Ducy
Journal:  Diabetologia       Date:  2011-04-19       Impact factor: 10.122

3.  Acute continuous moderate-intensity exercise, but not low-volume high-intensity interval exercise, attenuates postprandial suppression of circulating osteocalcin in young overweight and obese adults.

Authors:  L Parker; C S Shaw; E Byrnes; N K Stepto; I Levinger
Journal:  Osteoporos Int       Date:  2018-10-10       Impact factor: 4.507

Review 4.  Multifaceted interaction of bone, muscle, lifestyle interventions and metabolic and cardiovascular disease: role of osteocalcin.

Authors:  I Levinger; T C Brennan-Speranza; A Zulli; L Parker; X Lin; J R Lewis; B B Yeap
Journal:  Osteoporos Int       Date:  2017-03-13       Impact factor: 4.507

Review 5.  The role of osteocalcin in human glucose metabolism: marker or mediator?

Authors:  Sarah L Booth; Amanda Centi; Steven R Smith; Caren Gundberg
Journal:  Nat Rev Endocrinol       Date:  2012-11-13       Impact factor: 43.330

6.  Associations of total osteocalcin with all-cause and cardiovascular mortality in older men. The Health In Men Study.

Authors:  B B Yeap; S A P Chubb; L Flicker; K A McCaul; P R Ebeling; G J Hankey; J P Beilby; P E Norman
Journal:  Osteoporos Int       Date:  2011-02-26       Impact factor: 4.507

Review 7.  Osteocalcin in the brain: from embryonic development to age-related decline in cognition.

Authors:  Arnaud Obri; Lori Khrimian; Gerard Karsenty; Franck Oury
Journal:  Nat Rev Endocrinol       Date:  2018-01-29       Impact factor: 43.330

8.  The effects of muscle contraction and recombinant osteocalcin on insulin sensitivity ex vivo.

Authors:  I Levinger; X Lin; X Zhang; T C Brennan-Speranza; B Volpato; A Hayes; G Jerums; E Seeman; G McConell
Journal:  Osteoporos Int       Date:  2015-08-11       Impact factor: 4.507

9.  The effect of hyperinsulinaemic-euglycaemic clamp and exercise on bone remodeling markers in obese men.

Authors:  Itamar Levinger; Tara C Brennan-Speranza; George Jerums; Nigel K Stepto; Fabio R Serpiello; Glenn K McConell; Mitchell Anderson; David L Hare; Elizabeth Byrnes; Peter R Ebeling; Ego Seeman
Journal:  Bonekey Rep       Date:  2015-08-26

Review 10.  Bone and muscle: Interactions beyond mechanical.

Authors:  Marco Brotto; Lynda Bonewald
Journal:  Bone       Date:  2015-11       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.